Longeveron LGVN
NASDAQ LGVN
$0.84 +0.02 (+2.02%)
At close: Aug 21, 2026 · 4:00 PM EDT

Longeveron (LGVN) Net Equity Issued and Repurchased (2020 - 2025)

Longeveron (LGVN) posted quarterly Net Equity Issued and Repurchased of $15.9 million for Q4 2025, up 95.24% quarter-over-quarter from $8.1 million in Q3 2024.

Longeveron (LGVN) Net Equity Issued and Repurchased (2020 - 2025) Analysis & Trends

Longeveron's Net Equity Issued and Repurchased history runs 4 years deep, the most recent figure standing at $15.9 million for Q4 2025.

  • In Q4 2025, Net Equity Issued and Repurchased changed N/A year-over-year to $15.9 million; the TTM figure through Dec 2025 stood at $28.7 million (up 122.8% YoY), while the FY2025 annual figure was $5.0 million, down 61.29% from the prior year.
  • Net Equity Issued and Repurchased for Q4 2025 stood at $15.9 million, up from $8.1 million in the prior quarter.
  • The five-year high for Net Equity Issued and Repurchased was $26.7 million in Q1 2021, with the low at -$1000.0 in Q4 2021.
  • The 3-year median for Net Equity Issued and Repurchased is $6.4 million (2024), against an average of $9.2 million.
  • Peak annual rise in Net Equity Issued and Repurchased reached 2326.91% in 2021, while the deepest fall reached 2326.91% in 2021.
  • Longeveron's Net Equity Issued and Repurchased stood at -$1000.0 in 2021, then jumped by 814500.0% to $8.1 million in 2024, then surged by 95.24% to $15.9 million in 2025.
  • Business Quant data shows LGVN's Net Equity Issued and Repurchased at $15.9 million in Q4 2025, $8.1 million in Q3 2024, and $4.6 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Longeveron 26.51 Mn 16.41 Mn 182,000.00 -

Historic Data

Download Data
DateValue
Dec 31, 2025 15.90 Mn
Dec 31, 2025 15.90 Mn
Sep 30, 2024 8.14 Mn
Sep 30, 2024 8.14 Mn
Jun 30, 2024 4.62 Mn
Jun 30, 2024 4.62 Mn
Mar 31, 2024 100,000.00
Mar 31, 2024 100,000.00
Dec 31, 2021 -1,000.00
Dec 31, 2021 -1,000.00
Mar 31, 2021 26.70 Mn
Mar 31, 2021 26.70 Mn
Mar 31, 2020 1.10 Mn
Mar 31, 2020 1.10 Mn